Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugates

被引：0
|
作者：
Satake, Noriko [1 ]
Duong, Connie [1 ]
Oestergaard, Michael [2 ]
Yoshida, Sakiko [1 ]
Chen, Cathy [1 ]
Nolta, Jan A. [3 ]
Guo, Shuling [4 ]
Seth, Punit [2 ]
Nitin, Nitin [5 ]
Tuscano, Joseph [6 ]
机构：
[1] Univ Calif Davis, Sacramento, CA USA
[2] ISIS, Carlsbad, CA USA
[3] Univ Calif Davis, Sacramento, CA 95817 USA
[4] Isis Pharmaceut Inc, Carlsbad, CA USA
[5] Univ Calif Davis, Davis, CA USA
[6] Univ Calif Davis, Ctr Canc, Sacramento, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [32] PREVALENCE AND CLINICAL CHARACTERIZATION OF CD20 AND CD22 EXPRESSION IN PEDIATRIC PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Rayburg, Melissa S.
    Marmer, Daniel
    Mo, Jun
    McMasters, Richard
    Smolarek, Teresa
    Lampkin, Beatrice
    Perentesis, John
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 718 - 718
  • [33] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
  • [34] CD9 Confers Poor Survival in Pediatric B-Precursor Acute Lymphoblastic Leukemia and can be Effectively Targeted by Antibody Blockade
    Leung, K. T.
    Zhang, C.
    Cheung, J. T. K.
    Chan, K. Y. Y.
    Wang, H.
    Man, T. K. F.
    Li, K.
    Li, C. K.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S8 - S9
  • [35] Phase 1 Dose-Escalation Study of 90yttrium-Labeled Anti-CD22 Epratuzumab Tetraxetan in Adults with Refractory/Relapsed CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Chevallier, Patrice
    Eugene, Thomas
    Robillard, Nelly
    Isnard, Francoise
    Nicolini, Franck E.
    Escoffre-Barbe, Martine
    Huguet, Francoise
    Hunault, Mathilde
    Marcais, Antoine
    Guillaume, Thierry
    Delaunay, Jacques
    Peterlin, Pierre
    Thomas, Xavier
    Ifrah, Norbert
    Lapusan, Simona
    Bodet-Milin, Caroline
    Chauvet, Alain Faivre
    Le Houerou, Claire
    Goldenberg, David M.
    Wegener, William A.
    Kraeber-Bodere, Francoise
    BLOOD, 2014, 124 (21)
  • [36] Targeting B Cell Precursor Acute Lymphoblastic Leukemia (ALL) with Chimeric Antigen Receptors (CARs) Specific for CD19 or CD22
    Orentas, Rimas J.
    Haso, Waleed
    Lee, Daniel W.
    Fry, Terry J.
    Wayne, Alan S.
    Mackall, Crystal L.
    MOLECULAR THERAPY, 2013, 21 : S125 - S125
  • [37] Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review
    Becerril-Rico, Jared
    Delgado-Montes, Yerenia A. A.
    Ortiz-Sanchez, Elizabeth
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1822 - 1831
  • [38] Complete Remissions In 3 of 12 Patients with Pediatric Acute Lymphoblastic Leukemia (ALL) During Phase I Testing of the Anti-CD22 Immunotoxin Moxetumomab Pasudotox
    Wayne, Alan
    Bhojwani, Deepa
    Richards, Kelly
    Stetler-Stevenson, Maryalice
    Silverman, Lewis. B.
    Jeha, Sima
    Pui, Ching-Hon
    McDevitt, Jennifer
    FitzGerald, David J.
    Kreitman, Robert J.
    Lechleider, Robert J.
    Pastan, Ira
    BLOOD, 2010, 116 (21) : 1331 - 1331
  • [39] Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia
    Shah, Nirali N.
    Bhojwani, Deepa
    August, Keith
    Baruchel, Andre
    Bertrand, Yves
    Boklan, Jessica
    Dalla-Pozza, Luciano
    Dennis, Robyn
    Hijiya, Nobuko
    Locatelli, Franco
    Martin, Paul L.
    Mechinaud, Francoise
    Moppett, John
    Rheingold, Susan R.
    Schmitt, Claudine
    Trippett, Tanya M.
    Liang, Meina
    Balic, Kemal
    Li, Xia
    Vainshtein, Inna
    Yao, Nai Shun
    Pastan, Ira
    Wayne, Alan S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [40] CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
    Lanza, Francesco
    Maffini, Enrico
    Rondoni, Michela
    Massari, Evita
    Faini, Angelo Corso
    Malavasi, Fabio
    CANCERS, 2020, 12 (02)
12345